PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Address
303A COLLEGE ROAD EAST
PRINCETON, NJ 08540
Founded
2005
Number of Employees
25
Website
http://www.pdsbiotech.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)